Recombinant Human KLF7 Protein, N-His

Description of Recombinant Human KLF7 Protein, N-His

Title: Introduction to Recombinant Human KLF7 Protein

Recombinant human KLF7 protein is a highly versatile and valuable tool in the field of molecular biology. This protein is a member of the Krüppel-like factor (KLF) family of transcription factors, which play crucial roles in regulating gene expression and cellular processes. The recombinant form of KLF7 protein is produced through genetic engineering techniques, making it a powerful tool for studying its structure, activity, and applications.

Structure of Recombinant Human KLF7 Protein

The human KLF7 gene is located on chromosome 2 and encodes for a protein of 367 amino acids. The recombinant form of KLF7 protein is typically expressed in E. coli or mammalian cells, and its structure is similar to the native protein. It consists of a DNA-binding domain (DBD) and a transcriptional activation domain (TAD), which are essential for its function as a transcription factor.

The DBD of KLF7 protein contains three Cys2His2-type zinc fingers, which are responsible for binding to specific DNA sequences in the regulatory regions of target genes. The TAD, on the other hand, interacts with other transcriptional co-regulators to activate or repress gene expression. The recombinant form of KLF7 protein can also be modified to include additional functional domains, such as protein tags or fusion partners, to facilitate purification and detection.

Activity of Recombinant Human KLF7 Protein

The primary function of KLF7 protein is to regulate gene expression by binding to specific DNA sequences and modulating the activity of target genes. It has been shown to play important roles in various cellular processes, including cell proliferation, differentiation, and development. The activity of recombinant KLF7 protein can be studied using various techniques, such as electrophoretic mobility shift assays (EMSA) and chromatin immunoprecipitation (ChIP).

Recombinant KLF7 protein has also been shown to interact with other transcription factors and co-regulators, forming a complex network of regulatory proteins that control gene expression. This protein has been implicated in several diseases, including cancer, cardiovascular disorders, and neurological disorders, highlighting its potential as a therapeutic target.

Applications of Recombinant Human KLF7 Protein

The recombinant form of KLF7 protein has a wide range of applications in both basic research and drug development. Its ability to regulate gene expression makes it a valuable tool for studying the function of specific genes and their role in various cellular processes. It can also be used to identify potential drug targets and screen for compounds that modulate its activity.

Recombinant KLF7 protein has also been used in the development of gene therapy strategies for diseases caused by mutations or dysregulation of KLF7. It has been shown to have a protective effect on neurons in models of neurodegenerative diseases, making it a potential therapeutic agent for these conditions.

In addition, recombinant KLF7 protein has been used in the production of diagnostic kits for detecting KLF7 levels in patient samples. This can aid in the diagnosis and monitoring of diseases associated with KLF7 dysregulation.

Conclusion

In summary, recombinant human KLF7 protein is a valuable tool for studying its structure, activity, and applications. Its role as a transcription factor in regulating gene expression makes it an important player in various cellular processes and diseases. With its versatility and potential for therapeutic applications, recombinant KLF7 protein continues to be an essential component in the toolkit of molecular biologists.